Advertisement

Ads Placeholder
Loading...

Amundi Index Solutions - Amundi FTSE EPRA Europe Real Estate

EPRE.PAEURONEXT
Financial Services
Asset Management
325.30
1.44(0.45%)
U.S. Market opens in 20h 9m

Amundi Index Solutions - Amundi FTSE EPRA Europe Real Estate Fundamental Analysis

Amundi Index Solutions - Amundi FTSE EPRA Europe Real Estate (EPRE.PA) shows weak financial fundamentals with a PE ratio of 10.71, profit margin of 0.00%, and ROE of 0.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE0.00%
Operating Margin0.00%
Current Ratio0.00
We analyze EPRE.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 25.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
25.0/100

We analyze EPRE.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

EPRE.PA struggles to generate sufficient returns from assets.

ROA > 10%
0.00%

Valuation Score

Moderate

EPRE.PA shows balanced valuation metrics.

PE < 25
10.71
PEG Ratio < 2
N/A

Growth Score

Moderate

EPRE.PA shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

EPRE.PA shows balanced financial health with some risks.

Debt/Equity < 1
0.00
Current Ratio > 1
0.00

Profitability Score

Weak

EPRE.PA struggles to sustain strong margins.

ROE > 15%
0.00%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is EPRE.PA Expensive or Cheap?

P/E Ratio

EPRE.PA trades at 10.71 times earnings. This suggests potential undervaluation.

10.71

Debt/Equity

Amundi Index Solutions - Amundi FTSE EPRA Europe Real Estate has a debt-to-equity ratio of 0.00, indicating its leverage.

0.00

How Well Does EPRE.PA Make Money?

Net Profit Margin

For every $100 in sales, Amundi Index Solutions - Amundi FTSE EPRA Europe Real Estate keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $0.00 in profit for every $100 of shareholder equity.

0.00%

ROA

Amundi Index Solutions - Amundi FTSE EPRA Europe Real Estate generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.00%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.00

vs 25 benchmark

ROA

Return on assets percentage

0.00

vs 25 benchmark

ROCE

Return on capital employed

0.00

vs 25 benchmark

How EPRE.PA Stacks Against Its Sector Peers

MetricEPRE.PA ValueSector AveragePerformance
P/E RatioN/A18.66 N/A
ROE0.00%806.00% Weak
Net Margin0.00%-451.00% (disorted) Weak
Debt/Equity0.001.00 Strong (Low Leverage)
Current Ratio0.00662.02 Weak Liquidity
ROA0.00%-24409.00% (disorted) Weak

EPRE.PA outperforms its industry in 1 out of 5 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Amundi Index Solutions - Amundi FTSE EPRA Europe Real Estate's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

Fundamental Analysis FAQ